Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

Clinical trial NCT00738829 · COMPLETED

Trial details

NCT number: NCT00738829
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2008-10-01
Primary completion: 2012-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.